The pooled results from seven studies (45, 25, 26, 24, 27; and our study), including a total of 667 patients with ALS and 401 controls (Supplementary Table 3), showed no significant differences in serum IgM levels between patients with ALS and controls (Figure 2E). The gene discussed is CD40LG; the disease is amyotrophic lateral sclerosis.